Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Heidelberg
About this trial
Approximately one third of the population over the age of 65 falls at least once a year. The risk of falling is in increased in older patients with tumor diseases. In addition to high treatment and care costs for the healthcare system, falls often lead to a decrease of quality of life, a reduction in physical performance and a loss of independence. Despite the high risk, falls in cancer patients have not yet been scientifically investigated in detail. For patients with multiple myeloma in particular, very little data is available on the prevalence, risk factors and effects of falls. In this study, a fall risk assessment is carried out in patients with multiple myeloma. Furthermore, a patient-specific training intervention for fall prevention will be implemented.
The aim of the study is to identify possible fall risk factors in multiple myeloma patients and to establish a structured exercise intervention that minimizes the risk of falls and injuries.
Eligibility criteria
Qualifiers
Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy)
ECOG status ≤ 3
Age ≥18 years
Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits
Disqualifiers
Any physical or mental limitations that would prevent participation in the training program or the planned follow-up checks.
Trial design
Treatments tested in this trial
- Strength and balance training in combination with a treadmill-based pertubation intervention
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital Heidelberg
Lead sponsor
Bethanien Krankenhaus gGmbH
Collaborator
Source ClinicalTrials.gov